These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1227301)

  • 21. On the role of chemotherapy in the treatment of heroin addiction.
    Goldstein A
    Am J Drug Alcohol Abuse; 1975; 2(3-4):279-88. PubMed ID: 1227291
    [No Abstract]   [Full Text] [Related]  

  • 22. Evolution of the National Academy of Sciences study of naltrexone.
    Kaim SC
    NIDA Res Monogr; 1976 Sep; (9):37-44. PubMed ID: 794719
    [No Abstract]   [Full Text] [Related]  

  • 23. Narcotic antagonist treatment: clinical experience with naltrexone.
    Lewis DC; Mayer J; Hersch RG; Black R
    Int J Addict; 1978 Aug; 13(6):961-73. PubMed ID: 730406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison.
    Judson BA; Carney TM; Goldstein A
    Drug Alcohol Depend; 1981 Jul; 7(4):325-46. PubMed ID: 7023894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone and psychotherapy.
    Stone-Washton N; Resnick RB; Washton AM
    NIDA Res Monogr; 1982 Apr; 41():505-7. PubMed ID: 6811941
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of heroin addiction: naltrexone alone and with behavior therapy.
    Callahan EJ; Rawson RA; McCleave B; Arias R; Glazer M; Liberman RP
    Int J Addict; 1980 Aug; 15(6):795-807. PubMed ID: 7461877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naltrexone: a short-term treatment for opiate dependence.
    Greenstein RA; O'Brien CP; McLellan AT; Woody GE; Grabowski J; Long M; Coyle-Perkins G; Vittor A
    Am J Drug Alcohol Abuse; 1981; 8(3):291-300. PubMed ID: 7340503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of naltrexone.
    Renault PF
    NIDA Res Monogr; 1978; (19):340-5. PubMed ID: 106298
    [No Abstract]   [Full Text] [Related]  

  • 29. Naltrexone in the management of heroin addiction: critique of the rationale.
    Goldstein A
    NIDA Res Monogr; 1976 Sep; (9):158-61. PubMed ID: 187941
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical efficacy of naltrexone: a one year follow up.
    Resnick R; Aronoff M; Lonborg G; Kestenbaum R; Kauders F; Washton A; Hough G
    NIDA Res Monogr; 1976 Sep; (9):114-7. PubMed ID: 1088899
    [No Abstract]   [Full Text] [Related]  

  • 31. Naltrexone study guidelines: good vehicle--wrong destination.
    Brahen LS
    Am J Drug Alcohol Abuse; 1975; 2(3-4):451-3. PubMed ID: 1227303
    [No Abstract]   [Full Text] [Related]  

  • 32. Varying clinical contexts for administering naltrexone.
    Hurzeler M; Gerwirtz D; Kleber H
    NIDA Res Monogr; 1976 Sep; (9):48-66. PubMed ID: 794721
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of treatment compliance as a function of contingent payment manipulations.
    Grabowski J; O'Brien CP; Greenstein R; Long M; Steinberg-Donato S; Ternes J
    NIDA Res Monogr; 1979; 27():402-8. PubMed ID: 121360
    [No Abstract]   [Full Text] [Related]  

  • 35. Research and development of naltrexone: a new narcotic antagonist.
    Julius DA
    Am J Psychiatry; 1979 Jun; 136(6):782-6. PubMed ID: 220890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone and conventionality.
    Suffet F; Remine DC; Taleporos E; Brotman R
    Am J Drug Alcohol Abuse; 1978; 5(2):221-33. PubMed ID: 747176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1982; 10(2-3):269-82. PubMed ID: 7166139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Historical trends in naltrexone research.
    Julius DA
    NIDA Res Monogr; 1978; (19):301-7. PubMed ID: 106296
    [No Abstract]   [Full Text] [Related]  

  • 39. Naltrexone and cyclazocine. A controlled treatment study.
    Brahen LS; Capone T; Wiechert V; Desiderio D
    Arch Gen Psychiatry; 1977 Oct; 34(10):1181-4. PubMed ID: 911218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program.
    Schecter A; Kauders F
    Am J Drug Alcohol Abuse; 1975; 2(3-4):443-9. PubMed ID: 1227302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.